Why Is Enliven Therapeutics, Inc. (NASDAQ: ELVN) Stock Down Today?

Enliven Therapeutics, Inc. (NASDAQ: ELVN) Summary

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is trading down -0.55% at $59.32, reflecting a negative shift in investor sentiment today. The stock opened at $59.69 and has moved between $58.97 and $59.89 so far.

Trading volume is 1113059, which is 22% below its average, and the price action suggests selling interest.

Technically, ELVN on the NASDAQ is trading above its 50-day moving average of $55.46 and above its 200-day moving average of $37.45, indicating short-term and long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns ELVN a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -2.38% in 1 month ($57.91), -41.12% in 1 year ($34.93), and +13.91% in 5 years ($67.57).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.